Literature DB >> 12181371

The epidemiology of influenza.

I Stephenson1, M Zambon.   

Abstract

Influenza remains a globally important cause of febrile respiratory illness. Influenza virus activity in the community results in significant mortality, morbidity and economic disruption, particularly in those at high risk of developing complications, such as the elderly and those with underlying chronic medical conditions, including pulmonary disease and diabetes mellitus. The occurrence in Hong Kong in 1997 of avian influenza H5N1 in man, which resulted in six deaths, served to remind us of the importance of continuing surveillance and preparation for the next pandemic.

Entities:  

Mesh:

Year:  2002        PMID: 12181371      PMCID: PMC7313861          DOI: 10.1093/occmed/52.5.241

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  13 in total

1.  Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant.

Authors:  Tarek Hamouda; Joyce A Sutcliffe; Susan Ciotti; James R Baker
Journal:  Clin Vaccine Immunol       Date:  2011-05-04

2.  Estimating the undetected burden of influenza hospitalizations in children.

Authors:  C G Grijalva; G A Weinberg; N M Bennett; M A Staat; A S Craig; W D Dupont; M K Iwane; A S Postema; W Schaffner; K M Edwards; M R Griffin
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

Review 3.  Influenza virus and cell signaling pathways.

Authors:  Pratibha Gaur; Ashok Munjhal; Sunil K Lal
Journal:  Med Sci Monit       Date:  2011-06

4.  The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries.

Authors:  Liana Martirosyan; W John Paget; Pernille Jorgensen; Caroline S Brown; Tamara J Meerhoff; Dmitriy Pereyaslov; Joshua A Mott
Journal:  BMC Infect Dis       Date:  2012-02-10       Impact factor: 3.090

5.  Full Genome Characterization of Human Influenza A/H3N2 Isolates from Asian Countries Reveals a Rare Amantadine Resistance-Conferring Mutation and Novel PB1-F2 Polymorphisms.

Authors:  Hassan Zaraket; Hiroki Kondo; Akinobu Hibino; Ren Yagami; Takashi Odagiri; Nobuhiro Takemae; Ryota Tsunekuni; Takehiko Saito; Yi Yi Myint; Yadanar Kyaw; Khin Yi Oo; Htay Htay Tin; Nay Lin; Nguyen Phuong Anh; Nguyen Le Khanh Hang; Le Quynh Mai; Mohd R Hassan; Yugo Shobugawa; Julian Tang; Ghassan Dbaibo; Reiko Saito
Journal:  Front Microbiol       Date:  2016-03-07       Impact factor: 5.640

Review 6.  Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.

Authors:  Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

7.  A profile of the online dissemination of national influenza surveillance data.

Authors:  Calvin Ky Cheng; Eric Hy Lau; Dennis Km Ip; Alfred Sy Yeung; Lai Ming Ho; Benjamin J Cowling
Journal:  BMC Public Health       Date:  2009-09-16       Impact factor: 3.295

8.  Estimating influenza hospitalizations among children.

Authors:  Carlos G Grijalva; Allen S Craig; William D Dupont; Carolyn B Bridges; Stephanie J Schrag; Marika K Iwane; William Schaffner; Kathryn M Edwards; Marie R Griffin
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

Review 9.  On the epidemiology of influenza.

Authors:  John J Cannell; Michael Zasloff; Cedric F Garland; Robert Scragg; Edward Giovannucci
Journal:  Virol J       Date:  2008-02-25       Impact factor: 4.099

10.  The Influenza Primer Design Resource: a new tool for translating influenza sequence data into effective diagnostics.

Authors:  Michael E Bose; John C Littrell; Andrew D Patzer; Andrea J Kraft; Jacob A Metallo; Jiang Fan; Kelly J Henrickson
Journal:  Influenza Other Respir Viruses       Date:  2008-01       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.